Pilot Study of Daily Exemestane in Women With Complex Atypical Hyperplasia of the Endometrium/Endometrial Intraepithelial Neoplasia or Grade 1 Endometrial Cancer
Phase of Trial: Phase II
Latest Information Update: 28 Nov 2017
At a glance
- Drugs Exemestane (Primary)
- Indications Atypical endometrial hyperplasia; Endometrial cancer
- Focus Therapeutic Use
- 22 Nov 2017 Planned End Date changed from 1 Oct 2018 to 1 Jan 2019.
- 22 Nov 2017 Planned primary completion date changed from 1 Oct 2018 to 1 Jan 2019.
- 22 Nov 2017 Status changed from not yet recruiting to recruiting.